Endocrinology and metabolism clinics of north america: Type 2 diabetes and cardiovascular disease
Tipo de material: TextoIdioma: Inglés Detalles de publicación: Pennsylvania: Saunders, 2005.Edición: Primera EdiciónDescripción: 255 páginas; Volume 34 ilustraciones; tablas; gráficos; 23 centímetrosISBN:- 1-4160-2686-X
- 21 616.42 E35e
Contenidos:
Contents:
Management of diabetic dyslipidemia.
The dyslipidemia of diabetes mellitus.
Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile.
Hypertension management in type 2 diabetes mellitus.
Glycemic management of type 2 diabetes.
Hospital management of diabetes.
Potential cardiovascular benefits of insulin sensitizers.
Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus.
Novel pharmacologic agents for type 2 diabetes.
The prevention of type 2 diabetes mellitus.
Prevention of cardiovascular outcomes in type 2 diabetes mellitus.
Tipo de ítem | Biblioteca actual | Signatura | Estado | Fecha de vencimiento | Código de barras |
---|---|---|---|---|---|
Libros | Medicina | 616.42/E35e (Navegar estantería(Abre debajo)) | Disponible | MEDL002682 |
Contents:
Management of diabetic dyslipidemia.
The dyslipidemia of diabetes mellitus.
Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile.
Hypertension management in type 2 diabetes mellitus.
Glycemic management of type 2 diabetes.
Hospital management of diabetes.
Potential cardiovascular benefits of insulin sensitizers.
Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus.
Novel pharmacologic agents for type 2 diabetes.
The prevention of type 2 diabetes mellitus.
Prevention of cardiovascular outcomes in type 2 diabetes mellitus.
En español
No hay comentarios en este titulo.